PURPOSE: Chronic hepatitis B virus (HBV) infection is the major risk factor for hepatocellular carcinoma (HCC) in India. Studies from other countries have linked HBV genotype C to a higher risk for HCC. This study was carried out to determine the association between genotype and HCC and also the frequency of mutations in CTNNB1 (beta-catenin) and TP53 genes in HBV-related HCC. METHODS: Formalin-fixed paraffin-embedded (FFPE) tissues from 20 (15 autopsy, five resected specimens) cases of HBV-associated HCC were examined. Viral genotype was determined by sequencing portions of the HBV S gene using four overlapping PCR amplicons. Exon 3 of CTNNB1 and exon 7 of TP53 were sequenced. RESULTS: HBV genotyping was possible in 14 of 20 cases; genotype D was most common (n = 11) followed by C (n = 2) and A (n = 1). CTNNB1 mutations were noted in two of 15 amplifiable cases while two of 10 specimens showed TP53 mutations. CONCLUSIONS: HBV genotype can be ascertained from FFPE sections by sequencing multiple overlapping fragments to avoid the limitation of fragmented DNA. Genotype D was the common genotype in HBV-associated HCC. The very low frequency of TP53 mutation suggests low levels of aflatoxin B₁ exposure. The beta-catenin pathway appears not to be significantly involved in HBV-related HCC in India. However, further larger studies are required to confirm these findings.
PURPOSE:Chronic hepatitis B virus (HBV) infection is the major risk factor for hepatocellular carcinoma (HCC) in India. Studies from other countries have linked HBV genotype C to a higher risk for HCC. This study was carried out to determine the association between genotype and HCC and also the frequency of mutations in CTNNB1 (beta-catenin) and TP53 genes in HBV-related HCC. METHODS:Formalin-fixed paraffin-embedded (FFPE) tissues from 20 (15 autopsy, five resected specimens) cases of HBV-associated HCC were examined. Viral genotype was determined by sequencing portions of the HBV S gene using four overlapping PCR amplicons. Exon 3 of CTNNB1 and exon 7 of TP53 were sequenced. RESULTS:HBV genotyping was possible in 14 of 20 cases; genotype D was most common (n = 11) followed by C (n = 2) and A (n = 1). CTNNB1 mutations were noted in two of 15 amplifiable cases while two of 10 specimens showed TP53 mutations. CONCLUSIONS: HBV genotype can be ascertained from FFPE sections by sequencing multiple overlapping fragments to avoid the limitation of fragmented DNA. Genotype D was the common genotype in HBV-associated HCC. The very low frequency of TP53 mutation suggests low levels of aflatoxin B₁ exposure. The beta-catenin pathway appears not to be significantly involved in HBV-related HCC in India. However, further larger studies are required to confirm these findings.
Authors: J Y Park; Y N Park; D Y Kim; Y H Paik; K S Lee; B S Moon; K-H Han; C Y Chon; S H Ahn Journal: J Viral Hepat Date: 2008-06-28 Impact factor: 3.728
Authors: Michael Torbenson; Jae-Hyuk Lee; Michael Choti; Wesley Gage; Susan C Abraham; Elizabeth Montgomery; John Boitnott; Tsung-Teh Wu Journal: Mod Pathol Date: 2002-03 Impact factor: 7.842
Authors: K G Murugavel; P P Naranatt; E M Shankar; S Mathews; K Raghuram; P Rajasambandam; V Jayanthi; R Surendran; A Murali; U Srinivas; K R Palaniswamy; D Srikumari; S P Thyagarajan Journal: J Med Microbiol Date: 2007-11 Impact factor: 2.472
Authors: Li Zhou; Lin Lu; Max S Wicha; Alfred E Chang; Jian-chuan Xia; Xiubao Ren; Qiao Li Journal: Hum Vaccin Immunother Date: 2015 Impact factor: 3.452